FMCNA recognizes 25 dialysis patients across the nation

The nation's leading network of dialysis facilities is recognizing more than 25 patients across the nation who will be 100 years or older in 2012 and are still leading healthy, fulfilling lives without their kidney function. A healthy lifestyle has helped these dialysis patients reach the century mark in their lives.

Modern dialysis treatments are giving patients with kidney failure a better chance than ever to maintain a healthy, rewarding lifestyle for many years. Patient commitment to their treatment plan and to making changes in their lifestyle that address diet and exercise habits are important factors in doing well on dialysis. Some of Fresenius Medical Care North America's (FMCNA) centenarian patients have been on dialysis for many years. The company honors approximately 350 long-time patients annually with its Quarter Century Patient Recognition Program, which recognizes patients who have dedicated themselves to their treatment for 25 years or more.

One of the reasons that patients can live longer on dialysis today is that there are more treatment options available, and FMCNA is committed to offering a full range of services to its patients. The company offers free education sessions through its Treatment Options Program (TOPs), to educate patients about all available treatments for kidney failure, and encourages them to find the therapy that best suits their lifestyle and personal needs.

"Our number one goal is to provide the best quality care possible to help patients live a better life on dialysis. Seeing patients reach 100 years of age is extremely rewarding for our company and staff," said Dugan W. Maddux MD, FACP, Vice President, Chronic Kidney Disease Initiatives at FMCNA.

Comments

  1. How
    David David United States says:

    These patients must all have commercial insurance!

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New FDA award fuels research into autosomal dominant tubulointerstitial kidney disease